COMPANY
Early IS Good, Inc.
EARLY IS GOOD, INC. is listed on ClinicalTrials.gov as the lead sponsor of 1 study; the most recently updated is “Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer” (recruiting), in Bladder Cancer. From public records Source · Oct 12, 2026
Timeline
- Trial start —: Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05982561 | Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer | Not listed | Recruiting | Jul 26, 2023 | Aug 31, 2026 (estimated) |